However, retatrutide is still under study and not yet FDA-approved, while semaglutide is widely available and approved for both weight loss and diabetes management
In Parkinsons disease, oxidative stress contributes to the dysfunction and death of dopaminergic neurons in the substantia nigra, a hallmark of the disease pathology [237, 238]
This might happen if: Weight loss progress slows down Side effects are difficult to tolerate Blood sugar levels require better management Another medication may be better suited to the patients metabolism Instead of combining medications, providers typically transition patients carefully from one medication to another
Simultaneously, tirzepatide suppresses glucagon secretion, which helps prevent the liver from releasing excess glucose into the bloodstream
That knowledge could lead to better therapies, better care, and a better future for people like you